Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TSPO | P30536 | 2/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.30 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.30 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25816067 | 0.95 | KDM4E (0.38) | ATMKDM4EL3MBTL1TSPOHDAC4 | |
| SCHEMBL23814042 | 0.94 | ATM (0.40) | ATMKDM4EL3MBTL1PDE10AFAAH | |
| SCHEMBL17146800 | 0.93 | L3MBTL1 (0.46) | ATMKDM4EL3MBTL1TSPOALDH1A1 | |
| SCHEMBL23814241 | 0.91 | ATM (0.39) | ATMKDM4EL3MBTL1TSPOPDE10A | |
| SCHEMBL25459787 | 0.90 | TSPO (0.38) | ATMKDM4EL3MBTL1TSPOALDH1A1 | |
| SCHEMBL25459746 | 0.90 | TSPO (0.38) | ATMKDM4EL3MBTL1TSPOALDH1A1 | |
| SCHEMBL17265079 | 0.90 | KDM4E (0.35) | ATMKDM4EL3MBTL1 | |
| SCHEMBL25816086 | 0.90 | KDM4E (0.32) | ATMKDM4EL3MBTL1 | |
| SCHEMBL20857789 | 0.89 | L3MBTL1 (0.45) | ATMKDM4EL3MBTL1ALDH1A1HTT | |
| SCHEMBL25459736 | 0.88 | ATM (0.41) | ATMKDM4EL3MBTL1PDE10AFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230255106-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | MERCK PATENT GMBH (DE) | 2023-08-10 | — | — | US | disclosed |
| US-20230255106-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | MERCK PATENT GMBH (DE) | 2023-08-10 | — | — | US | disclosed |
| US-20230172062-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | MERCK PATENT GMBH (DE) | 2023-06-01 | — | — | US | disclosed |
| US-20230172062-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | MERCK PATENT GMBH (DE) | 2023-06-01 | — | — | US | disclosed |
| US-20230157151-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | MERCK PATENT GMBH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-20230157151-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | MERCK PATENT GMBH (DE) | 2023-05-18 | — | — | US | disclosed |
| WO-2021239772-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | MERCK PATENT GMBH (DE) | 2021-12-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172062-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | SLC29A1, SLC19A2, NUDT1 | ATM 3823/4885KDM4E 3835/4885L3MBTL1 2253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.